LIVIVO - Search results -

Search results

Result 1 - 10 of total 4515

Search options

Article ; Online: First report of inherited protein S deficiency caused by paternal

Nagaya, Satomi / Maruyama, Keiko / Watanabe, Atsushi / Meguro-Horike, Makiko / Imai, Yuta / Hiroshima, Yuki / Horike, Shin-Ichi / Kokame, Koichi / Morishita, Eriko

Haematologica

2022 Volume 107, Issue 1, Page(s) 330–333

MeSH term(s)	Humans ; Mosaicism ; Pedigree ; Protein S/genetics ; Protein S Deficiency/diagnosis ; Protein S Deficiency/genetics ; Thrombophilia
Chemical Substances	PROS1 protein, human ; Protein S
Language	English
Publishing date	2022-01-01
Publishing country	Italy
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2333-4
ISSN	1592-8721 ; 0017-6567 ; 0390-6078
ISSN (online)	1592-8721
ISSN	0017-6567 ; 0390-6078
DOI	10.3324/haematol.2021.278527
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uh III Zs.76: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Protein S deficiency caused by cryptic splicing due to the novel intron variant c.346+5G>C in PROS1.

Nagaya, Satomi / Togashi, Tomoki / Akiyama, Masaharu / Imai, Yuta / Matsumoto, Haruto / Moriya, Haruka / Meguro-Horike, Makiko / Yasuda, Ibuki / Kikuchi, Yuika / Kuwajima, Yamato / Horike, Shin-Ichi / Watanabe, Atsushi / Morishita, Eriko

Thrombosis research

2023 Volume 229, Page(s) 26–30

Language	English
Publishing date	2023-06-24
Publishing country	United States
Document type	Letter
ZDB-ID	121852-9
ISSN	1879-2472 ; 0049-3848
ISSN (online)	1879-2472
ISSN	0049-3848
DOI	10.1016/j.thromres.2023.06.020
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 863: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article: Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan.

Kobayashi, Takao / Sugiura, Kazuko / Ojima, Toshiyuki / Serizawa, Mariko / Hirai, Kyuya / Morishita, Eriko

Thrombosis journal

2024 Volume 22, Issue 1, Page(s) 18

Abstract: ... characteristics. Antithrombin (AT) deficiency, protein C (PC) deficiency and protein S (PS) deficiency are ...

Abstract	Background: We previously conducted a primary survey of pregnant women with hereditary thrombophilia based on national surveillance in Japan, but did not examine their thrombosis-related characteristics. Antithrombin (AT) deficiency, protein C (PC) deficiency and protein S (PS) deficiency are the major types of hereditary thrombophilia in Japan. Methods: We examined their detailed information related to thrombosis, and evaluated peripartum outcomes in comparison with control data obtained from the Japan Society of Obstetrics and Gynecology. Results: Definite or probable AT deficiency, PC deficiency and PS deficiency were observed in 80, 50, and 317 pregnancies, respectively, from 2014 to 2018 in Japan, with prevalence rates among total deliveries of 0.011%, 0.007%, 0.044%. The number of pregnancies with AT, PC and PS deficiency might have been as many as 27, 17 and 108 every year if complete answers had been provided. In the peripartum period of current pregnancies, 27.5% of women with AT deficiency, 28.0% with PC deficiency and 13.2% with PS deficiency developed thrombosis (p < 0.001 vs. control). Pregnant women with AT and PC deficiency were more susceptible to thrombosis than those with PS deficiency (P < 0.01). Of the thromboses, 92.3% occurred during pregnancy, 62.8% at less than 15 gestational weeks. The earliest onset of thrombosis was 5 gestational weeks. Prophylactic anticoagulation significantly prevented the onset of both antepartum and postpartum thrombosis (p < 0.0001). The rate of recurrent pregnancy loss in women with low PC or PS activities was significantly higher than in controls (p < 0.0001); however, it is unknown whether recurrent pregnancy loss is related to hereditary PS deficiency. There seem to have been few serious maternal or fetal/neonatal complications due to placental insufficiency related to a hypercoagulable state other than growth restriction. Conclusions: This survey revealed the thrombosis-related characteristics of pregnant women with hereditary thrombophilia in Japan. We suggest prophylactic anticoagulation to prevent maternal or fetal/neonatal complications.
Language	English
Publishing date	2024-02-08
Publishing country	England
Document type	Journal Article
ZDB-ID	2118392-2
ISSN	1477-9560
ISSN	1477-9560
DOI	10.1186/s12959-024-00581-z
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Evaluation of Optimal Sample Processing Conditions for Accurate Measurement of Protein S Activity.

Nagaya, Satomi / Araiso, Yuhei / Yamaguchi, Koichi / Omote, Yuichiro / Matsui, Asaka / Asakura, Hidesaku / Morishita, Eriko

Annals of clinical and laboratory science

2021 Volume 51, Issue 2, Page(s) 206–212

Abstract: Objective: Protein S(PS) activity, especially PS-specific activity calculated by total PS activity ...

Abstract	Objective: Protein S(PS) activity, especially PS-specific activity calculated by total PS activity (tPSAct) divided by total PS antigen (tPSAg), is important in the diagnosis of hereditary PS deficiency (PSD). The cleavage of PS at a thrombin-sensitive region (TSR) by proteases reduces the anticoagulant activity of PS. Therefore, we investigated the effect of sample processing and storage on tPSAct and PS cleavage. Methods: Blood samples were collected from ten healthy subjects, and tPSAg and tPSAct were measured in whole blood or plasma stored at room temperature (RT) or 4°C. The cleaved PS was detected by western blotting, and the relationship between decreases in PS-specific activity and increase rates of cleaved PS was evaluated. Furthermore, the stability of tPSAg and tPSAct on the long-term storage of plasma was also evaluated. Results: Both whole blood and plasma stored at RT and whole blood stored at 4°C showed decreased tPSAct (50-80%) after 24 hours ( Conclusion: Inappropriate processing and storage result in falsely low PS-specific activity due to the cleavage of PS in the blood collection tubes, which may lead to misdiagnosis of PSD. Samples should be centrifuged immediately after collection, and the plasma should be frozen.
MeSH term(s)	Adult ; Blood Specimen Collection/methods ; Female ; Healthy Volunteers ; Humans ; Male ; Plasma/chemistry ; Protein S/analysis ; Protein S/drug effects ; Protein S/metabolism ; Protein S Deficiency/diagnosis ; Specimen Handling/methods ; Temperature
Chemical Substances	PROS1 protein, human ; Protein S
Language	English
Publishing date	2021-04-06
Publishing country	United States
Document type	Journal Article
ZDB-ID	193092-8
ISSN	1550-8080 ; 0091-7370 ; 0095-8905
ISSN (online)	1550-8080
ISSN	0091-7370 ; 0095-8905
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 942: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Effect on Plasma Protein S Activity in Patients Receiving the Factor Xa Inhibitors.

Terakami, Takako / Nagaya, Satomi / Hayashi, Kenshi / Furusho, Hiroshi / Fujino, Noboru / Kato, Takeshi / Asakura, Hidesaku / Morishita, Eriko

Journal of atherosclerosis and thrombosis

2021 Volume 29, Issue 7, Page(s) 1059–1068

Abstract: Aims: Measurement of protein S (PS) activity in patients taking direct oral anticoagulants (DOACs ...

Abstract	Aims: Measurement of protein S (PS) activity in patients taking direct oral anticoagulants (DOACs) using reagents based on a clotting assay results in falsely high PS activity, thus masking inherited PS deficiency, which is most frequently seen in the Japanese population. In this study, we investigated the effect of factor Xa (FXa) inhibitors on PS activity using the reagent on the basis of the chromogenic assay, which was recently developed in Japan. Methods: The study enrolled 152 patients (82 males and 70 females; the average age: 68.5±14.0 years) receiving three FXa inhibitors (rivaroxaban, edoxaban, and apixaban). PS activity was measured using the reagents on the basis of the clotting and chromogenic assays. Results: PS activity measured by the clotting assay reagents exhibited falsely high values depending on the plasma concentrations of FXa inhibitors in patients taking either rivaroxaban or edoxaban. However, none of the three FXa inhibitors affected PS activity when measured using the chromogenic assay. Conclusion: In patients taking rivaroxaban or edoxaban, inherited PS deficiency is likely missed because the levels of PS activity measured using the reagents based on the clotting assay are falsely high. However, we report that three FXa inhibitors do not affect PS activity measured by the chromogenic assay. When measuring the levels of PS activity in patients undergoing DOACs, the principles of each reagent should be understood. Furthermore, plasma samples must be collected at the time when plasma concentrations of DOACs are lowest or the DOAC-Stop reagent should be used.
MeSH term(s)	Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/pharmacology ; Blood Coagulation ; Factor Xa/pharmacology ; Factor Xa Inhibitors/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Protein S/analysis ; Rivaroxaban/pharmacology ; Rivaroxaban/therapeutic use ; Thrombophilia
Chemical Substances	Anticoagulants ; Factor Xa Inhibitors ; Protein S ; Rivaroxaban (9NDF7JZ4M3) ; Factor Xa (EC 3.4.21.6)
Language	English
Publishing date	2021-07-30
Publishing country	Japan
Document type	Journal Article
ZDB-ID	2011474-6
ISSN	1880-3873 ; 1340-3478
ISSN (online)	1880-3873
ISSN	1340-3478
DOI	10.5551/jat.62951
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5192: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Comparative evaluation of reagents for measuring protein S activity: possibility of harmonization.

Ieko, Masahiro / Hotta, Taeko / Watanabe, Kumiko / Adachi, Tomoko / Takeuchi, Sawako / Naito, Sumiyoshi / Yoshida, Mika / Ohmura, Kazumasa / Takahashi, Nobuhiko / Morishita, Eriko / Tsuda, Hiroko / Kang, Dongchon

International journal of hematology

2021 Volume 113, Issue 4, Page(s) 530–536

Abstract: Patients with congenital protein S (PS) deficiency show a hereditary predisposition for thrombosis ... at three facilities using three reagents for measuring PS: STA-Staclot Protein S (STA-PS), HemosIL ... Protein S (Clotting) (IL-PS), and a total PS assay (SNT-PS). The within-run precision of each reagent was ...

Abstract	Patients with congenital protein S (PS) deficiency show a hereditary predisposition for thrombosis, and PS deficiency is prevalent among Japanese populations. Diagnosis is based on symptoms of thrombosis and reduced PS activity. Three reagents that use different measurement principles for determining PS activity are available in Japan. This study aimed to confirm the possibility of harmonization of these three reagents to establish a universal standard for PS activity in Japanese populations. Commercial normal plasma and plasma samples obtained from healthy individuals and healthy pregnant women were tested at three facilities using three reagents for measuring PS: STA-Staclot Protein S (STA-PS), HemosIL Protein S (Clotting) (IL-PS), and a total PS assay (SNT-PS). The within-run precision of each reagent was good, as each had a coefficient of variation of ≤ 3.8%. The dilution linearity for each reagent was also good. The correlation coefficient was 0.94 for STA-PS vs. IL-PS, 0.93 for SNT-PS vs. STA-PS, and 0.90 for SNT-PS vs. IL-PS, indicating a good correlation. Although the three reagents available in Japan for measuring PS activity use different measurement methods, each showed good performance, and large differences were not observed between the obtained values. Harmonization among them appears possible.
MeSH term(s)	Biological Assay/methods ; Biological Assay/standards ; Blood Coagulation ; Humans ; Protein S/metabolism ; Protein S Deficiency/blood ; Protein S Deficiency/diagnosis ; Reagent Kits, Diagnostic/standards ; Reference Values ; Reproducibility of Results
Chemical Substances	Protein S ; Reagent Kits, Diagnostic
Language	English
Publishing date	2021-01-08
Publishing country	Japan
Document type	Journal Article
ZDB-ID	1076875-0
ISSN	1865-3774 ; 0917-1258 ; 0925-5710
ISSN (online)	1865-3774
ISSN	0917-1258 ; 0925-5710
DOI	10.1007/s12185-020-03049-8
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 269: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Sphyraena stellata, a new barracuda from the Indo-Pacific, with redescriptions of S. helleri Jenkins, 1901 and S. novaehollandiae Günther, 1860 (Perciformes: Sphyraenidae).

Morishita, Satoshi / Motomura, Hiroyuki

Zootaxa

2020 Volume 4772, Issue 3, Page(s) zootaxa.4772.3.6

Abstract: ... In addition, S. helleri Jenkins, 1901 and S. novaehollandiae Günther, 1860, both being closely related ...

Abstract	A new barracuda, Sphyraena stellata, is described on the basis of 41 specimens [98.0-587.0 mm standard length (SL)] collected from the Indo-Pacific. The new species can be distinguished from all congeners in having the following combination of characters: one gill raker on first gill arch; pelvic-fin insertion located slightly before vertical through first dorsal-fin origin; pored lateral-line scales 134-141 (modally 137), total lateral-line scales 139-148 (146); scales above and below lateral line 15-17 (15) and 14-16 (15), respectively; snout comparatively short, its length 13.6-15.8 (mean 14.4) % SL; upper jaw short, its posterior tip not reaching to below anterior nostril, its length 10.0-12.2 (10.8) % SL; eye small, orbit diameter and depth 4.3-7.0 (4.9) and 3.9-5.6 (4.5) % SL, respectively; anal-fin base shortish, its length 6.9-8.1 (7.5) % SL; last dorsal- and anal-fin ray lengths 4.0-5.6 (4.7) and 3.6-5.6 (4.6) % SL, respectively; anus not close to anal-fin origin, anterior and posterior margins of former to anal-fin origin 7.5-11.9 (9.9) and 5.2-8.3 (6.8) % of head length, respectively; head sensory canal pores on suborbital area simple or slightly branched, their lowermost parts not close to margin of lacrimal bone, large smooth area lacking canal pores on mid-margin of lacrimal bone; two yellow stripes on lateral surface of body (remaining as black stripes in preserved specimens); and caudal fin gray. In addition, S. helleri Jenkins, 1901 and S. novaehollandiae Günther, 1860, both being closely related to the new species, are redescribed on the basis of 4 (243.3-545.8 mm SL) and 15 (270.8-598.0 mm SL) specimens, including holotypes, respectively, with new diagnostic characters proposed for both species.
MeSH term(s)	Animals ; Color ; Gills ; Head ; Perciformes
Language	English
Publishing date	2020-05-11
Publishing country	New Zealand
Document type	Journal Article
ISSN	1175-5334
ISSN (online)	1175-5334
DOI	10.11646/zootaxa.4772.3.6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Personalized Medicine in Parkinson’s Disease

Takayasu Mishima / Shinsuke Fujioka / Takashi Morishita / Tooru Inoue / Yoshio Tsuboi

Journal of Personalized Medicine, Vol 11, Iss 650, p

New Options for Advanced Treatments

2021 Volume 650

Abstract: Parkinson’s disease (PD) presents varying motor and non-motor features in each patient owing ...

Abstract	Parkinson’s disease (PD) presents varying motor and non-motor features in each patient owing to their different backgrounds, such as age, gender, genetics, and environmental factors. Furthermore, in the advanced stages, troublesome symptoms vary between patients due to motor and non-motor complications. The treatment of PD has made great progress over recent decades and has directly contributed to an improvement in patients’ quality of life, especially through the progression of advanced treatment. Deep brain stimulation, radiofrequency, MR–guided focused ultrasound, gamma knife, levodopa-carbidopa intestinal gel, and apomorphine are now used in the clinical setting for this disease. With multiple treatment options currently available for all stages of PD, we here discuss the most recent options for advanced treatment, including cell therapy in advanced PD, from the perspective of personalized medicine.
Keywords	Parkinson’s disease ; deep brain stimulation ; levodopa-carbidopa intestinal gel ; apomorphine ; radiofrequency ; focused ultrasound ; Medicine ; R
Subject code	610
Language	English
Publishing date	2021-07-01T00:00:00Z
Publisher	MDPI AG
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: [A Case of Anastomotic Stenosis with Reconstructed Small Intestine Mucosal Damage during Taking S-1 Orally after Gastrectomy for Gastric Cancer].

Shibata, Ryosuke / Kaida, Hiroki / Koreeda, Toshihiko / Morishita, Marina / Hirano, Yosuke / Omiya, Toshihiro / Uwatoko, Shugo / Komono, Akira / Kawamoto, Makoto / Sakamoto, Ryohei / Miyasaka, Yoshihiro / Higashi, Daijiro / Haraoka, Seiji / Nimura, Satoshi / Watanabe, Masato

Gan to kagaku ryoho. Cancer & chemotherapy

2022 Volume 48, Issue 13, Page(s) 1960–1962

Abstract: ... S-1 as an adjuvant chemotherapy 7 weeks after gastrectomy. Seventeen days later after taking S-1 ...

Abstract	An 83-year-old woman underwent laparoscopic distal gastrectomy and Billroth Ⅱ reconstruction for gastric cancer. Since histopathological examination revealed that the lesion was Stage ⅢA, she had started taking S-1 as an adjuvant chemotherapy 7 weeks after gastrectomy. Seventeen days later after taking S-1 administration, she felt nauseous and self-interrupted. Nineteen days later, she was urgently hospitalized. Esophagogastroduodenoscopy(EGD)showed anastomotic lumen was open, but reconstructed small intestine mucosal damage was found, and reconstructed small intestine muscle layer was fused to anastomotic region. On 50th day of hospitalization, mucosa was regenerated and endoscopic balloon dilatation (EBD)was performed from 78th day. She was discharged on 151th day of hospitalization after 7 times of EBD. One year later, she does not need EBD and can be taken orally and has no recurrence.
MeSH term(s)	Aged, 80 and over ; Constriction, Pathologic ; Female ; Gastrectomy/adverse effects ; Gastroenterostomy ; Humans ; Laparoscopy ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/surgery
Language	Japanese
Publishing date	2022-01-16
Publishing country	Japan
Document type	Case Reports ; Journal Article
ZDB-ID	604842-0
ISSN	0385-0684
ISSN	0385-0684
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 2573: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Racial differences in protein S Tokushima and two protein C variants as genetic risk factors for venous thromboembolism.

Tsuda, Hiroko / Noguchi, Kenta / Oh, Doyeun / Bereczky, Zsuzsanna / Lee, Lai H / Kang, Dongchon / Dusse, Luci M S / das G Carvalho, Maria / Morishita, Eriko

Research and practice in thrombosis and haemostasis

2020 Volume 4, Issue 8, Page(s) 1295–1300

Abstract: ... polymorphisms previously identified as genetic risk factors among East Asian subpopulations: protein S (PS ...

Abstract	Background: Racial differences in genetic risk factors for venous thromboembolism (VTE) are elucidated, with factor V Leiden and prothrombin G20210A being prevalent among the Caucasian population but rare among non-Caucasians. Objectives: To assess the worldwide distribution of three gene polymorphisms previously identified as genetic risk factors among East Asian subpopulations: protein S (PS) Tokushima (p.Lys196Glu), protein C (PC) p.Arg189Trp, and PC p.Lys193del. Methods: An international collaborative study group of seven centers in five countries-Japan, South Korea, Singapore, Hungary, and Brazil-was created, and genotype analyses were performed. A total of 2850 unrelated individuals (1061 patients with VTE and 1789 controls) were included. Results: PS Tokushima was confined to Japanese patients with VTE (allele frequency, 2.35%) and controls (1.12%), with an odds ratio (OR) of 2.15 (95% confidence interval, 1.16-3.99). PC p.Arg189Trp carriers were prevalent among Chinese and Malay patients with VTE in Singapore, with allele frequencies of 10.53% and 22.73%, respectively. Carriers of PC p.Lys193del were identified among Japanese and Korean patients with VTE (0.87% and 2.35%, respectively) and controls (0.36% and 1.07%, respectively), with the OR for VTE not being significant, and Chinese patients with VTE in Singapore (5.26%). In contrast, no carriers of PS Tokushima and two PC gene variants were found among patients with VTE or controls from Hungary, Brazil, or Indians in Singapore. Conclusion: The three variants were prevalent among East and Southeast Asians, having some differences in geographic distribution, but were absent among Caucasian subpopulations and Brazilians.
Language	English
Publishing date	2020-10-20
Publishing country	United States
Document type	Journal Article
ISSN	2475-0379
ISSN (online)	2475-0379
DOI	10.1002/rth2.12440
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED